Swiss Market Holds Steady Amid Mixed US Openings; UBS Regulatory Loss Weighs on Blue Chips

The Swiss Market Index (SMI) opened the day with minimal gains, holding just above its break-even line at 14,028.96 points, following a cautious start to trading. The index’s performance was influenced by a mixed US market opening, where futures for the Dow Jones and Nasdaq remained flat, while the S&P 500 futures edged up by 0.1 percent to 7,836 points. At midday, the SMI expanded its gains to 0.1 percent, though the broader SPI index declined by 0.1 percent to 19,815.33 points, while the mid-cap SMIM fell 0.4 percent to 3,125.75 points. The SMI’s gains were led by Swiss Re (+1.0 percent), Nestlé (+0.8 percent), and Novartis (+0.7 percent), while UBS (-0.2 percent) reversed early gains, reflecting regulatory pressure after the Ständerat’s decision on stricter capital requirements for systemically important banks. The ruling required foreign subsidiaries of Swiss banks to hold 90 percent of their core capital (CET1) rather than the previously proposed 50 percent mix of CET1 and AT1 bonds, which are less costly. UBS, which had opposed the stricter rules, faced a setback in its capital structure, contributing to its losses. Meanwhile, Roche (+0.5 percent) saw modest gains after reporting positive data for its drug candidate Sefaxersen, though earlier research results had not triggered a similar reaction. Swiss Life (-0.9 percent) and construction sector firms Sika (-0.9 percent) and Geberit (-0.6 percent) underperformed, while tech stocks like Logitech (+0.7 percent) and Holcim (+0.6 percent) performed better. Tech sector gains extended to AMS Osram (+8.3 percent) and VAT (+1.9 percent), supported by analyst upgrades and Nasdaq highs. EFG International (+4.9 percent) benefited from resolving a long-standing dispute with Kuwait’s PIFSS, while Peach Property (+2.2 percent) reported improved half-year results despite ongoing losses. DocMorris (-4.4 percent) and Roche’s Roche (-0.2 percent) struggled amid legal and operational challenges. The broader market sentiment was tempered by geopolitical developments, including renewed US-Iran talks at the UN’s General Assembly, which briefly eased oil prices but left tensions unresolved. US-China relations also remained a focal point, with potential implications for trade and geopolitical stability. The Swiss National Bank’s upcoming Zinsentscheid on Thursday could further shape market expectations, while US economic data and earnings reports remained a key driver for investor sentiment. The SMI’s mixed performance reflected both domestic regulatory pressures and global uncertainty, with gains in sectors like tech and pharmaceuticals offset by losses in banking and construction.